GR3003631T3 - - Google Patents
Info
- Publication number
- GR3003631T3 GR3003631T3 GR910401306T GR910401306T GR3003631T3 GR 3003631 T3 GR3003631 T3 GR 3003631T3 GR 910401306 T GR910401306 T GR 910401306T GR 910401306 T GR910401306 T GR 910401306T GR 3003631 T3 GR3003631 T3 GR 3003631T3
- Authority
- GR
- Greece
- Prior art keywords
- nifedipine
- concentrate
- vitamin
- surfactant
- appropriate
- Prior art date
Links
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 3
- 229960001597 nifedipine Drugs 0.000 abstract 3
- 239000012141 concentrate Substances 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP86117660A EP0272336B1 (de) | 1986-12-18 | 1986-12-18 | Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3003631T3 true GR3003631T3 (en, 2012) | 1993-03-16 |
Family
ID=8195654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR910401306T GR3003631T3 (en, 2012) | 1986-12-18 | 1992-01-23 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4904699A (en, 2012) |
| EP (1) | EP0272336B1 (en, 2012) |
| JP (1) | JPS63165318A (en, 2012) |
| AT (1) | ATE68704T1 (en, 2012) |
| DE (1) | DE3682208D1 (en, 2012) |
| ES (1) | ES2040697T3 (en, 2012) |
| GR (1) | GR3003631T3 (en, 2012) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3738236A1 (de) * | 1987-11-11 | 1989-05-24 | Euro Celtique Sa | Beisskapsel |
| HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
| US5145859A (en) * | 1991-03-20 | 1992-09-08 | Case Western Reserve University | Methods of treating interstitial cystitis and urethral syndrome |
| US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
| BE1006990A5 (nl) * | 1993-04-22 | 1995-02-07 | Univ Gent | Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen. |
| US5662933A (en) * | 1993-09-09 | 1997-09-02 | Edward Mendell Co., Inc. | Controlled release formulation (albuterol) |
| US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5773025A (en) | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
| US6726930B1 (en) * | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5994348A (en) | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
| JP3148256B2 (ja) | 1996-07-08 | 2001-03-19 | エドワード メンデル カンパニー．，インコーポレーテッド | 高用量難溶性薬物用持続放出マトリックス |
| IN186245B (en, 2012) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
| US6056977A (en) | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
| US6168806B1 (en) | 1999-03-05 | 2001-01-02 | Fang-Yu Lee | Orally administrable nifedipine pellet and process for the preparation thereof |
| DE19913692A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| HK1042427A1 (zh) * | 1999-09-30 | 2002-08-16 | Penwest Pharmaceuticals Co. | 用於高溶度药物的持续释放基质方法 |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| DE60028754T2 (de) * | 1999-11-12 | 2007-05-31 | Abbott Laboratories, Abbott Park | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
| DE10026698A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| CA2519779A1 (en) * | 2003-03-26 | 2004-10-14 | Teva Pharmaceutical Industries Ltd. | A process for preparing a pharmaceutical active ingredient with high specific surface area |
| US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| CA2669938C (en) * | 2006-11-15 | 2016-01-05 | Abbott Laboratories | Solid pharmaceutical dosage formulations |
| GB0703514D0 (en) * | 2007-02-23 | 2007-04-04 | Univ Ulster | Use of riboflavin |
| JP6215238B2 (ja) * | 2012-02-16 | 2017-10-18 | テバ ファーマシューティカル インダストリーズ リミティド | Ｎ−エチル−ｎ−フェニル−１，２−ジヒドロ−４，５−ジ−ヒドロキシ−１−メチル−２−オキソ−３−キノリンカルボキサミド、その製剤、および使用 |
| CA2968861C (en) | 2017-05-30 | 2022-10-11 | University Of Saskatchewan | Topical nifedipine formulations and uses thereof |
| KR20210089219A (ko) | 2018-11-07 | 2021-07-15 | 디에스엠 아이피 어셋츠 비.브이. | 개선된 유동성을 나타내는 리보플라빈을 함유하는 약제 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU432703A3 (en, 2012) * | 1971-08-24 | 1974-06-15 | Фридрих Боссерт, Вульф Фатер, Курт Бауер | |
| GB1579818A (en) * | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
| GB2111978B (en) * | 1981-10-19 | 1985-05-01 | Maruko Pharmaceutical Co | 1 4-dihydropyridine compounds |
| DE3339236A1 (de) * | 1983-10-28 | 1985-05-09 | Bayer Ag | Arzneimittelzubereitung |
| DE3438830A1 (de) * | 1984-10-23 | 1986-04-30 | Rentschler Arzneimittel | Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung |
| DE3532129A1 (de) * | 1985-09-10 | 1987-03-12 | Bayer Ag | Ss-carotin enthaltende gelatine |
-
1986
- 1986-12-18 EP EP86117660A patent/EP0272336B1/de not_active Expired - Lifetime
- 1986-12-18 AT AT86117660T patent/ATE68704T1/de not_active IP Right Cessation
- 1986-12-18 ES ES198686117660T patent/ES2040697T3/es not_active Expired - Lifetime
- 1986-12-18 DE DE8686117660T patent/DE3682208D1/de not_active Expired - Lifetime
-
1987
- 1987-12-07 US US07/129,767 patent/US4904699A/en not_active Expired - Fee Related
- 1987-12-15 JP JP62315404A patent/JPS63165318A/ja active Pending
-
1992
- 1992-01-23 GR GR910401306T patent/GR3003631T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0272336A1 (de) | 1988-06-29 |
| ES2040697T3 (es) | 1993-11-01 |
| JPS63165318A (ja) | 1988-07-08 |
| DE3682208D1 (de) | 1991-11-28 |
| US4904699A (en) | 1990-02-27 |
| ATE68704T1 (de) | 1991-11-15 |
| EP0272336B1 (de) | 1991-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3003631T3 (en, 2012) | ||
| GR3000536T3 (en) | Penetration enhancement systems and the preparation thereof | |
| NO170126C (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat | |
| DK554084A (da) | 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol | |
| IT8523299A0 (it) | Derivati. processo per la preparazione di (2,2)-paraciclofano e suoi | |
| DK631688D0 (da) | 2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme | |
| EP0227450A3 (en) | Substituted 5,6-dialkoxyquinazoline derivatives | |
| DZ768A1 (fr) | Dérivés de l'hydroxy-4-2h-1-benzothiopyran-2-one, leurs préparations et applications. | |
| NZ217184A (en) | Alleviating cytopathic effects of htlv-iii virus on cells using 2',3'-dideoxycytidine | |
| EP0331092A3 (en) | Alpha-amino-carboxylic-acid derivatives, their preparation and use | |
| ZA91115B (en) | Topical compositions | |
| EP0204586A3 (en) | Stabilizer for hair compositions and such compositions | |
| EP0249193A3 (en) | Vehicle for topical application of pharmaceuticals | |
| IT8420213A0 (it) | Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi. | |
| Ghosh | Geochemistry of the Nelson-Rossland Area, Southeastern British Columbia | |
| NO860273L (no) | Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner. | |
| EP0098568A3 (en) | Corticoids-containing preparation for topical application | |
| IT8521765A0 (it) | Tensioattivi derivati dall'acido succinico. | |
| TR23271A (tr) | En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul | |
| DE3575727D1 (de) | Herstellung von 2,6-dialkylphenoxydihalophosphiten. | |
| NO863094D0 (no) | Fremgangsmaate for fremstilling av 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxylsyrer. | |
| 小田光宏 | White, MD “Evaluation of the reference interview” | |
| Lamont | Les Gens de L'air: French as the Language of Work, 1976 | |
| Pedras | Metabolites of the Scleroderris canker fungus | |
| ZA874878B (en) | Pyran derivatives |